{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:01:28Z","timestamp":1792731688031,"version":"4.5.0"},"reference-count":15,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychoactive Drugs"],"published-print":{"date-parts":[[2003,6,1]]},"DOI":"10.1080\/02791072.2003.10400007","type":"journal-article","created":{"date-parts":[[2011,9,7]],"date-time":"2011-09-07T10:57:39Z","timestamp":1315393059000},"page":"253-259","source":"Crossref","is-referenced-by-count":921,"title":["The Clinical Opiate Withdrawal Scale (COWS)"],"prefix":"10.1080","volume":"35","author":[{"given":"Donald R.","family":"Wesson","sequence":"first","affiliation":[{"name":"a   CNS Medications Development  , Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ling","sequence":"additional","affiliation":[{"name":"b   Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences , David Geffen School of Medicine at University of California Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2011,9,7]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1973.03220160036009"},{"key":"CIT0002","first-page":"1465","volume":"2","author":"Blachly P. H.","year":"1973","journal-title":"Proceedings of the National Conference on Methadone Treatment"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197204272861718"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1987.tb03294.x"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4603(90)90036-W"},{"issue":"7","key":"CIT0006","first-page":"450","volume":"29","author":"Haertzen C. A.","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1970.tb01159.x"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.3109\/00952998709001515"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-15-5-829"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.94.4.759"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(91)90059-8"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1989.tb00737.x"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(89)90078-1"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1974164653"},{"key":"CIT0015","volume-title":"Buprenorphine in Pharmacotherapy of Opioid Addiction: Implementation in Office-Based Medical Practice; Translating the Experience of Clinical Trials into Clinical Practice.","author":"Wesson D. R.","year":"1999"}],"container-title":["Journal of Psychoactive Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02791072.2003.10400007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T09:02:21Z","timestamp":1597654941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02791072.2003.10400007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,1]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,6,1]]}},"alternative-id":["10.1080\/02791072.2003.10400007"],"URL":"https:\/\/doi.org\/10.1080\/02791072.2003.10400007","relation":{},"ISSN":["0279-1072","2159-9777"],"issn-type":[{"value":"0279-1072","type":"print"},{"value":"2159-9777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,1]]}}}